Simplify Logo

Full-Time

Manager – Clinical Quality Assurance

Confirmed live in the last 24 hours

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulators for medical conditions

Hardware
Biotechnology

Compensation Overview

$144.8k - $170.3kAnnually

Senior, Expert

San Carlos, CA, USA

Category
QA & Testing
Quality Assurance
Required Skills
Quality Assurance (QA)
Google Cloud Platform
Requirements
  • Lead/manage Good Clinical Practice (GCP) audits, including clinical investigator site audits, clinical vendor audits, clinical department internal audits, Trial Master File (TMF) audits, and applicable study document audits, including Clinical Study Reports (CSRs)
  • Serve as a QA representative and support clinical study teams to provide compliance advice
  • Participate in review and approval of clinical study documents and clinical SOPs / Guidance Documents
  • Manage study-specific Study Audit Plans compliance for the assigned program by using a risk-based approach for Corcept clinical studies
  • Review and approve investigational product (IP) temperature excursions to ensure release or rejection of IP on time
  • Lead continuous improvement of the Clinical Quality Management Systems (CQMS) and processes, including creation and revision of SOPs for GCP compliance and excellence
  • Manage and support inspection readiness activities for GCP
  • Support clinical inspections conducted by regulatory agencies, including sponsor inspections, clinical investigator site inspections, and contract research organization (CRO) inspections
  • Support GMP, GLP, and PV inspections
  • Lead clinical non-compliance event investigations and CAPA implementation
  • Perform quality metric analysis for CQA including study quality event trends from clinical process deviations / CAPAs to include a review of protocol deviations, safety, and other clinical data
  • Maintain a contemporary knowledge of agency and industry trends, standards, and methodologies related to GCPs. Maintain the GCP regulatory surveillance program
  • Provide cross-training development opportunities to QA team members, and mentor/coach junior QA team members upon request or as an assigned supervisor
  • Some travel required
Responsibilities
  • Understanding of Quality Systems that support GCP quality activities
  • Experience developing GCP processes for the best industry practices and training
  • Strong proficiency in Microsoft Office
  • BS / BA (science or related field) or equivalent experience
  • 6 or more years clinical research experience

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Company Stage

IPO

Total Funding

$119.1M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

4%

1 year growth

10%

2 year growth

31%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investments from firms like Intrinsic Edge Capital and Jackson Creek Investment Advisors indicate strong market confidence in Corcept's growth potential.
  • The appointment of experienced leaders like Roberto Vieira and Monica Tellado suggests a strategic focus on expanding into oncology and emerging markets.
  • Corcept's commitment to patient and medical education enhances its reputation and fosters better patient outcomes.

What critics are saying

  • Ongoing legal disputes, such as the antitrust lawsuit from Teva, could result in financial and operational setbacks.
  • The loss of the Korlym patent lawsuit to Teva poses a significant threat to Corcept's revenue stream from its flagship product.

What makes Corcept Therapeutics unique

  • Corcept Therapeutics specializes exclusively in cortisol modulation, setting it apart from broader-focused biopharmaceutical companies.
  • Their flagship product, Korlym, is the first FDA-approved treatment for hypercortisolism in Cushing's syndrome, giving them a unique market position.
  • Corcept's extensive R&D pipeline with over 1,000 discovered selective cortisol modulators highlights their commitment to innovation in this niche field.